A Dose-Finding Study of E7050 Administered Orally to Patients With Advanced Solid Tumors

NCT00869895 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
60
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Eisai Inc.